These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38679644)

  • 21. Once-Weekly Insulin Icodec
    Ribeiro E Silva R; de Miranda Gauza M; Guisso MES; da Silva JON; Kohara SK
    Arch Endocrinol Metab; 2023 May; 67(5):e000614. PubMed ID: 37249450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5) : A Randomized Trial.
    Bajaj HS; Aberle J; Davies M; Donatsky AM; Frederiksen M; Yavuz DG; Gowda A; Lingvay I; Bode B
    Ann Intern Med; 2023 Nov; 176(11):1476-1485. PubMed ID: 37748181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of the initial period of basal insulin titration in people with diabetes.
    Khunti K; Giorgino F; Berard L; Mauricio D; Harris SB
    Diabetes Obes Metab; 2020 May; 22(5):722-733. PubMed ID: 31865632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial.
    Russell-Jones D; Babazono T; Cailleteau R; Engberg S; Irace C; Kjaersgaard MIS; Mathieu C; Rosenstock J; Woo V; Klonoff DC
    Lancet; 2023 Nov; 402(10413):1636-1647. PubMed ID: 37863084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 1 diabetes.
    Hövelmann U; Engberg S; Heise T; Kristensen NR; Nørgreen L; Zijlstra E; Ribel-Madsen R
    Diabetes Obes Metab; 2024 May; 26(5):1941-1949. PubMed ID: 38379002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment.
    Rosenstock J; Bajaj HS; Janež A; Silver R; Begtrup K; Hansen MV; Jia T; Goldenberg R;
    N Engl J Med; 2020 Nov; 383(22):2107-2116. PubMed ID: 32960514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysis.
    Saleem SZ; Fareed A; Akhtar SMM; Farhat S; Taha AM; Akilimali A
    Diabetol Metab Syndr; 2024 Apr; 16(1):80. PubMed ID: 38566252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The future of insulin therapy.
    Heise T
    Diabetes Res Clin Pract; 2021 May; 175():108820. PubMed ID: 33865915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Clar C; Marien M; Richter B; Philip S
    Health Technol Assess; 2010 Jul; 14(36):1-248. PubMed ID: 20646668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Once-Weekly Insulin Regimes on Glycemic Control for Type 2 Diabetes: A Systematic Review and Network Meta-analysis.
    Wang P; Zhang Y; Xu W; He J; Peng L; Feng Y; Xu P; Chong W; Hai Y; Jia L; Fang F
    Diabetol Metab Syndr; 2024 Jan; 16(1):3. PubMed ID: 38172995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 2 diabetes.
    Pieber TR; Asong M; Fluhr G; Höller V; Kristensen NR; Larsen JH; Ribel-Madsen R; Svehlikova E; Vinther S; Voortman M; Haahr H
    Diabetes Obes Metab; 2023 Dec; 25(12):3716-3723. PubMed ID: 37694740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes.
    Bajaj HS; Goldenberg RM
    touchREV Endocrinol; 2023 May; 19(1):4-6. PubMed ID: 37313230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100.
    Lingvay I; Buse JB; Franek E; Hansen MV; Koefoed MM; Mathieu C; Pettus J; Stachlewska K; Rosenstock J
    Diabetes Care; 2021 Jul; 44(7):1595-1603. PubMed ID: 33875484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of once-weekly basal insulin versus once-daily basal insulin in patients with type 2 diabetes: A systematic review and meta-analysis.
    Wang X; Xiao W; Liang Z; Li S; Tang Q
    Medicine (Baltimore); 2023 Dec; 102(52):e36308. PubMed ID: 38206709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine.
    Warren E; Weatherley-Jones E; Chilcott J; Beverley C
    Health Technol Assess; 2004 Nov; 8(45):iii, 1-57. PubMed ID: 15525480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial.
    Bue-Valleskey JM; Kazda CM; Ma C; Chien J; Zhang Q; Chigutsa E; Landschulz W; Haupt A; Frias JP
    Diabetes Care; 2023 May; 46(5):1060-1067. PubMed ID: 36944059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes.
    Kazda CM; Bue-Valleskey JM; Chien J; Zhang Q; Chigutsa E; Landschulz W; Wullenweber P; Haupt A; Dahl D
    Diabetes Care; 2023 May; 46(5):1052-1059. PubMed ID: 36920867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.